FULC
Fulcrum Therapeutics Inc
3.70$
-0.5%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | +166.7% | -7.6% | +128.6% | +13.3% | -8.5% | +12.6% | +2.5% | -48.8% | -27.4% | -37.1% | -42.1% | -56.9% | +198.3% | -13.7% | +14.8% | -100.0% | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -68.6% | +24.3% | -96.2% | +2,690.4% | -11.8% | +22.4% | +3.2% | +1.2% | +6.4% | -1.7% | +10.7% | -5.7% | +40.3% | -38.6% | -96.2% | +2,728.3% | +6.8% | +2.2% | -97.2% | -5.7% | +3,503.5% | -15.2% | -97.5% | +3,532.5% | -97.8% | +4,665.3% | -102.1% | – | -36.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -17,568.1% | – | – | – | -232.0% | – | -123.3% | – | – | – | – | – | -212.7% | – | – | |
| – | +3.9% | +20.3% | -1.5% | +404.8% | -68.6% | +24.3% | -14.3% | +25.2% | -11.8% | +22.4% | +3.2% | +1.2% | +6.4% | -1.7% | +10.7% | -5.7% | +40.3% | -38.6% | +20.8% | -10.0% | +6.8% | +2.2% | +4.2% | +1.6% | -10.5% | -15.2% | -22.5% | +18.2% | -3.1% | +10.1% | +7.8% | -8.6% | -11.6% | – | |
| – | +18.7% | +3.1% | +12.5% | +8.7% | +1.4% | +33.3% | +25.4% | +9.8% | +2.5% | +7.2% | +10.4% | -9.8% | +22.8% | +29.4% | +22.9% | -0.1% | +2.5% | -13.6% | +10.9% | +7.2% | -10.6% | -4.0% | +5.8% | +2.0% | -0.8% | -18.4% | -5.2% | -13.3% | +2.0% | +6.9% | -0.3% | +11.3% | -7.9% | – | |
| – | +7.4% | +15.8% | +1.8% | +302.4% | -63.8% | +26.0% | -6.1% | -68.3% | +1.7% | +3.2% | +10.4% | -6.3% | +21.6% | +29.1% | +12.5% | +10.9% | +3.2% | -8.3% | +182.1% | -59.9% | -10.4% | -3.5% | +184.7% | +3.5% | -65.1% | +2.3% | +81.7% | -63.3% | +178.8% | -61.3% | +204.1% | -5.0% | -9.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -147.9% | – | – | – | – | – | – | – | – | |
| – | +0.0% | – | – | – | – | – | – | – | – | – | – | – | -22.7% | +58.8% | +38.9% | -6.7% | +135.7% | +273.9% | +197.9% | +72.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -139.2% | – | – | – | – | – | – | – | – | |
| – | – | -2,860.0% | – | – | – | – | – | – | – | – | – | – | – | – | -3,368.4% | – | – | – | -900.3% | – | – | -22.2% | +673.0% | -86.2% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -139.2% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -140.7% | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.